Capricor Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs...
Q1 2026
May 13, 2026
FY 2025
Mar 17, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 11, 2025